Edition:
United States

Sartorius AG (SATG_p.DE)

SATG_p.DE on Xetra

108.20EUR
23 Feb 2018
Change (% chg)

€2.10 (+1.98%)
Prev Close
€106.10
Open
€108.00
Day's High
€110.10
Day's Low
€106.60
Volume
150,194
Avg. Vol
92,318
52-wk High
€110.50
52-wk Low
€69.59

Chart for

About

Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates through two segments: Bioprocess Solutions and Lab Products and Services. The Bioprocess Solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media,... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 31.28 16.59
EPS (TTM): -- -- --
ROI: -- 9.69 35.07
ROE: -- 14.25 17.79

BRIEF-Sartorius Sees Sales Rising To Around 4 Bln Euros In 2025

* ‍NEW MEDIUM-TERM TARGETS: UNDERLYING EBITDA MARGIN OF ABOUT 28 PERCENT IN 2025​

Feb 21 2018

BRIEF-Sartorius To Propose Dividend Of EUR 0.51 Per Preference Share And EUR 0.50 Per Ordinary Share

* DIVIDENDS TO RISE TO 0.51 EUROS PER PREFERENCE SHARE AND 0.50 EUROS PER ORDINARY SHARE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Feb 20 2018

BRIEF-Sartorius Sees 2018 Sales Growth Of Up To 12 Pct

* SARTORIUS GROWS SIGNIFICANTLY AGAIN IN SALES REVENUE AND EARNINGS IN 2017 – POSITIVE OUTLOOK FOR 2018

Jan 31 2018

BRIEF-Sartorius AG says ‍full-year 2017 guidance adjusted

* 9 ‍months business performance of Bioprocess solutions division in 2017 temporary weaker than expected ​

Oct 16 2017

Earnings vs. Estimates